Economic evaluation in HTA Medicines R&D Economic evaluation in HTA is a comparison of costs and consequences of health technologies. Read more »
Ethical, social, and legal issues (ELSI) in HTA Medicines R&D HTA bodies must take into account ethical, legal, and social issues (ELSI) during their assessments of health technologies. Read more »
Patient-reported outcomes (PROs) assessment Medicines R&D Patient-reported outcomes (PROs) focus on real benefits important to and achievable for patients. Read more »
Governance and structure of HTA bodies Medicines R&D HTA bodies vary from place-to-place and are established in rough correspondence to a health system. Read more »
Patient involvement in HTA Medicines R&D The way patients are involved in an HTA body depends on the political and cultural context. Patient involvement in HTA should be developed as the result of a partnership... Read more »
Health Technology Assessment process: Fundamentals Medicines R&D Health Technology Assessment (HTA) processes are varied, but some fundamentals apply. Read more »
Principles for Health Technology Assessment Bodies Medicines R&D The International Working Group for for HTA Advancement has developed a set of fifteen key principles for health technology assessment bodies. Read more »
The extent of patient involvement in HTA processes Medicines R&D In this video, three patient advocates discuss the extent of patient involvement in HTA processes. Read more »
